WV AG Says Purdue Pharma Bankruptcy Plan Ignores Intensity Of States’ Opioid Problems
CHARLESTON, WV (WOWK) – West Virginia Attorney General Patrick Morrisey Says He Will vote no on the confirmation of Purdue Pharma’s bankruptcy plan.
Morrisey says that Purdue’s proposed settlement fund allocation plan focuses on population size, not the disproportionate damage opioids have caused, particularly in West Virginia.
“I remain vigorously opposed to a proposed allocation formula that would allocate settlement funds largely based on the population of a state or local government – not the intensity of the problem,” said Morrisey. “Such an award formula does not recognize the disproportionate damage caused by opioids in our state. I look forward to taking our case to court in August.
In April, Morrisey filed his objection based on Purdue’s failure to disclose how his multibillion-dollar proposal would be split among states undermines his desire to avoid legal challenges to what Morrisey sees as an unfair deal. in the United States Bankruptcy Court for the Southern District of New York.
In May 2019, Morrisey filed a lawsuit against Purdue Pharma and former CEO Richard Sackler. The lawsuit alleges that Purdue Pharma created a false narrative to convince prescribers that opioids are not addictive and that its opioid products were safer than they actually were. The lawsuit says Purdue Pharma had a deceptive marketing strategy and alleges that company sales representatives have consistently claimed that OxyContin does not have a dose cap, despite claims by federal regulators that the dose cap d ‘OxyContin was evident from side effects.
The lawsuit marked West Virginia’s second against Purdue Pharma. The first, filed in 2001, resulted in a settlement of $ 10 million in 2004. However, this case involved an earlier version of the opioid than the reformulated, so-called tamper-evident OxyContin, which debuted in 2010.
The Purdue lawsuit is one of the West Virginia attorney general’s pending lawsuits against five opioid manufacturers and other national distribution chains.